Dr. Vojnic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
210 East 64th Street
New York, NY 10065
Summary
- Morana Vojnic, MD is a New York-based oncologist who specializes in Neuro-Oncology and Thoracic Cancer. An alumnus of the Faculty of Medicine at the University of Ljubljana, class of 2012, Dr. Vojnic possesses a comprehensive range of experience in her chosen field. Her research contributions include publications in reputable journals such as Nature Cancer, Neuro-Oncology Advances, Clinical Neurology, Neurosurgery, and Journal of Neuro-Oncology. Several of these articles have been cited by other publications multiple times, exemplifying the influence of her work in the scientific community.
Education & Training
- University of Ljubljana Faculty of MedicineClass of 2012
Certifications & Licensure
- CT State Medical License 2019 - 2025
- NJ State Medical License 2019 - 2025
- NY State Medical License 2019 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Prioritizing Radiation and Targeted Systemic Therapies in Patients with Resected Brain Metastases from Lung Cancer Primaries with Targetable Mutations: A Report from a...Yen-Ruh Wuu, Mostafa Kokabee, Bin Gui, Simon Lee, Jacob Stone
Cancers. 2024-09-26 - Combination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers andAmplification.Arielle Elkrief, Igor Odintsov, Roger S Smith, Morana Vojnic, Takuo Hayashi
JCO Precision Oncology. 2024-09-01 - Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mut...Isao Miyazaki, Igor Odintsov, Keiji Ishida, Allan J W Lui, Masanori Kato
Nature Cancer. 2023-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: